A Study in Healthy Male Volunteers Investigating the Safety, Absorption and Elimination of Single Doses of GLPG4059
Clinical trial NCT04575818 · TERMINATED
Trial details
- NCT number
- NCT04575818
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-16
- Primary completion
- 2021-04-08
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.